CCO Oncology Podcast

Gastroenteropancreatic Neuroendocrine Tumors: Diagnosis, Findings, and Recommendations

Episode Summary

Listen as Thor R. Halfdanarson, MD, and Jonathan Strosberg, MD, discuss the diagnosis and typical presenting symptoms of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) as well as findings from recent phase III studies including NETTER-2 and CABINET. Notable clinical pearls regarding GEP-NET therapies and current guidelines for GEP-NET care and monitoring are also highlighted.

Episode Notes

In this episode, Thor R. Halfdanarson, MD, and Jonathan Strosberg, MD, discuss important topics related to gastroenteropancreatic neuroendocrine tumors (GEP-NETs), including:

• The diagnosis and typical presenting symptoms of GEP-NETs
• Findings from recent key phase III studies including NETTER-2 and CABINET
• Recommendations for treatment sequencing
• Notable clinical pearls regarding GEP-NET therapies
• Current guidelines for GEP-NET care and monitoring

Presenters:

Thor R. Halfdanarson, MD
Consultant, Division of Medical Oncology
Professor of Oncology
Associate Professor of Medicine
Mayo Clinic Comprehensive Cancer Center
Chair, Hepato-Pancreatico-Biliary Disease Group
Rochester, Minnesota

Jonathan Strosberg
Professor, GI Oncology
Chair, Neuroendocrine Tumor Division
Moffitt Cancer Center and Research Institute
Tampa, Florida

Link to full program: 
https://bit.ly/3Y0JWBa